Entrepreneurs: Why Peptides Are the Next Revolution in Personalized Medicine with Delphine Le Grand

Discover entrepreneurship, innovation, business growth, scaling, and intellectual property strategies from successful founders and industry leaders. Richard Gearhart and Elizabeth Gearhart, co-hosts of the Passage to Profit Show interview Delphine Le Grand from The Protocole. GLP-1 medications like Ozempic have sparked worldwide interest in peptides—but that's only the beginning. Delphine Le Grand, Co-founder of The Protocole, explains what peptides are, how they may support recovery, weight management, sleep, cognitive performance, healthy aging, and regenerative wellness, and why personalized treatment is essential. Learn why working with knowledgeable clinicians matters, how peptide therapy differs from supplements and traditional medications, and what the future of personalized health could look like as peptide research continues to expand. Read more at: https://theprotocole.com/ Whether you're a seasoned entrepreneur, startup founder, inventor, or small business owner, the Passage to Profit Show is a leading podcast for insights on entrepreneurship, innovation, intellectual property and business strategy. Hosted by Richard Gearhart and Elizabeth Gearhart, the show features industry leaders, investors, and founders who share real-world lessons on scaling companies, protecting ideas, building generational wealth, and navigating today’s evolving business landscape. Visit https://passagetoprofitshow.com/ for the latest episodes, expert interviews, and resources designed to help you grow, protect, and profit from your ideas.